704 related articles for article (PubMed ID: 15297779)
1. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
2. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
3. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial.
Scholten T; Dekkers CP; Schütze K; Körner T; Bohuschke M; Gatz G
Digestion; 2005; 72(2-3):76-85. PubMed ID: 16113546
[TBL] [Abstract][Full Text] [Related]
4. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease.
Tolia V; Bishop PR; Tsou VM; Gremse D; Soffer EF; Comer GM;
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):384-91. PubMed ID: 16641576
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
Wurzer H; Schutze K; Bethke T; Fischer R; Luhmann R; Riesenhuber C
Hepatogastroenterology; 1999; 46(27):1809-15. PubMed ID: 10430350
[TBL] [Abstract][Full Text] [Related]
6. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
7. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease.
Kaspari S; Biedermann A; Mey J
Digestion; 2001; 63(3):163-70. PubMed ID: 11351143
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
[TBL] [Abstract][Full Text] [Related]
11. Esomeprazole versus pantoprazole for healing erosive oesophagitis.
Vcev A; Begić I; Ostojić R; Jurcić D; Bozić D; Soldo I; Gmajnić R; Kondza G; Khaznadar E; Mićunović N
Coll Antropol; 2006 Sep; 30(3):519-22. PubMed ID: 17058517
[TBL] [Abstract][Full Text] [Related]
12. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
Digestion; 2005; 71(3):152-8. PubMed ID: 15870503
[TBL] [Abstract][Full Text] [Related]
13. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
Dupas JL; Houcke P; Samoyeau R;
Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
[TBL] [Abstract][Full Text] [Related]
14. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
Bochenek WJ; Mack ME; Fraga PD; Metz DC
Aliment Pharmacol Ther; 2004 Nov; 20(10):1105-14. PubMed ID: 15569113
[TBL] [Abstract][Full Text] [Related]
15. [Financial restrictions in health care systems could affect treatment quality of GERD-patients].
Gillessen A; Schöffel L; Naumburger A
Z Gastroenterol; 2006 May; 44(5):379-85. PubMed ID: 16688654
[TBL] [Abstract][Full Text] [Related]
16. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.
Pratha V; Hogan DL; Lynn RB; Field B; Metz DC
Dig Dis Sci; 2006 Sep; 51(9):1595-601. PubMed ID: 16927137
[TBL] [Abstract][Full Text] [Related]
17. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
Richter JE; Bochenek W
Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
[TBL] [Abstract][Full Text] [Related]
18. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
19. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Farley A; Wruble LD; Humphries TJ
Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
Chen TS; Chang FY; Ng WW; Lee FY; Hwang SJ; Lee SD
Hepatogastroenterology; 1999; 46(28):2372-8. PubMed ID: 10522000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]